METTL3 and colorectal carcinoma: This suppression disrupts the regulatory mechanism whereby METTL3 modulates the expression of cyclin E1 (CCNE1) by methylating the m6A site within its 3’-UTR in CCNE1 mRNA, thereby inhibiting CRC progression.